■ LECTURE OVERVIEW: Hodgkin Lymphoma is a clonal B-cell malignancy characterized by the presence of pathognomonic giant tumor cells in a polymorphic background of reactive immune cells.
■ PATHOGNOMONIC HISTOLOGY & FLOW:
1. Giant Tumor Cells: The diagnostic hallmark is the Reed-Sternberg (RS) cell—a giant cell (20-40 microns) with abundant pale cytoplasm.
2. Owl Eyes: RS cells typically possess a bilobed or multilobed nucleus, with each lobe containing an extraordinarily prominent, acidophilic (pink) nucleolus surrounded by a clear halo, creating a classic 'owl-eye' appearance.
3. B-Cell Rearrangements: Though arising from mutated B-lineage cells in germinal centers, RS cells have lost their classical B-cell surface markers (such as CD20 and surface immunoglobulins).
4. Immunophenotype: Diagnostic RS cells are immunophenotypically positive for CD15 and CD30 but negative for CD45.
■ IMMUNOLOGICAL & CYTOKINE SIGNALLING FLUX:
Pathogen exposure or cellular distress triggers antigen-presenting cell activation. This results in the release of pro-inflammatory cytokines (such as IL-1, TNF-alpha, and IL-6) and triggers receptor-mediated cellular chemotaxis.
■ EMERGENCY DECREES & FAST-TRACK RESPONSES:
Upon presentation with extreme physiological disruption, initiate immediate volume restoration and broad-spectrum metabolic stabilization.
[HY-BOARD-1256]
🌟 Dynamic Clinical Key:
Classic Hodgkin Lymphoma peaks in young adults (bimodal age distribution: 15-35 and >55 years). It typically presents with painless cervical lymphadenopathy and systemic 'B symptoms' (fever, night sweats, weight loss) driven by systemic cytokine release from tumor cells. Target specific monoclonal antibodies or immune suppressors to control the hyper-inflammatory cascade. Confirm central vital markers continually rather than relying solely on peripheral readings.